Otolaryngology
Partner With Us
Advertisement

Head and Neck Cancer

thumb description

July 03, 2025

Is HPV-Driven SNSCC Its Own Disease?

Researchers identified key genetic differences between HPV-associated and HPV-independent sinonasal squamous cell carcinoma, revealing distinct mutations, survival risks, and potential treatment targets.

Conexiant

thumb description

June 23, 2025

Is Smoking a Surgical Risk Multiplier?

A study of nearly 700 patients found that smokers undergoing surgery for esophageal cancer experienced significantly more complications, including higher rates of pneumonia and respiratory distress, than nonsmokers—though smoking did not independently impact long-term survival.

Conexiant

thumb description

June 20, 2025

Hormone Levels May Guard Against MetS

A large national study of U.S. women ages 12 to 49 found that higher levels of testosterone and sex hormone–binding globulin were linked to lower odds of metabolic syndrome, with differences observed across racial and ethnic groups.

Conexiant

thumb description

June 19, 2025

Chronic Cannabis Use Linked to Vascular Impairment

A new cross-sectional study in healthy adults found that chronic marijuana smoking and edible THC use were linked to reduced endothelial function, an early marker of vascular disease risk.

Conexiant

thumb description

February 10, 2024

Using 3D Modeling to Enhance Surgery Among Patients With Paralyzed Vocal Cords

Diana N. Kirke, MD, is heading a first-ever study into the potential of 3D modeling of the paraglottic space to facilitate medialization laryngoplasty. The technology is expected to shorten the surgery while making it easier to perform and result in improved patient outcomes, surgical efficiency, and cost efficiency.

Mount Sinai New York

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

thumb description

June 16, 2025

Cytisinicline Shows Efficacy In Smoking Cessation Trial 

A phase 3 randomized clinical trial found that cytisinicline, a partial agonist at α4β2 nicotinic acetylcholine receptors, improved smoking cessation rates compared with placebo, with higher abstinence rates and reduced craving over 24 weeks.

Conexiant